58 results on '"Chen, Zhe-Sheng"'
Search Results
2. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration
3. New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
4. Targeting anoikis resistance as a strategy for cancer therapy
5. VISTA: A Novel Checkpoint for Cancer Immunotherapy
6. Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
7. Ferroptosis as a potential therapeutic target for age-related macular degeneration
8. ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
9. Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor
10. Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions
11. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
12. lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2
13. Antimicrobial peptides for combating drug-resistant bacterial infections
14. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond
15. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
16. Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
17. CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis
18. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance
19. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
20. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
21. Mechanisms of thrombosis and research progress on targeted antithrombotic drugs
22. Novel nanomedicines to overcome cancer multidrug resistance
23. Recent progress on targeting leukemia stem cells
24. The role of endolysosomal trafficking in anticancer drug resistance
25. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
26. Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
27. The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
28. Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
29. Therapeutic strategies to overcome taxane resistance in cancer
30. The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
31. Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
32. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
33. Chloroquine against malaria, cancers and viral diseases
34. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
35. The combination of disulfiram and copper for cancer treatment
36. Recent progress in antitumor functions of the intracellular antibodies
37. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
38. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
39. Revisiting mTOR inhibitors as anticancer agents
40. Modulating ROS to overcome multidrug resistance in cancer
41. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
42. Exploring naturally occurring ivy nanoparticles as an alternative biomaterial
43. Silver nanoparticles: synthesis, properties, and therapeutic applications
44. The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
45. Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3′-azido-3′-deoxythymidine as anticancer prodrugs
46. Triterpenoids as reversal agents for anticancer drug resistance treatment
47. Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
48. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
49. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine
50. Design, synthesis and biological evaluation of WZ4002 analogues as EGFR inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.